DDAVP (desmopressin acetate) by Ferring Pharmaceuticals is clinical pharmacology ddavp tablets contain as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. Approved for primary nocturnal enuresis. First approved in 1995.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
DDAVP (desmopressin acetate) is a synthetic analogue of arginine vasopressin that acts as an antidiuretic agent. It is primarily indicated for primary nocturnal enuresis and central diabetes insipidus, working by increasing urine osmolality and reducing urinary output. The oral tablet formulation has approximately 5% bioavailability compared to intranasal administration, with onset of antidiuretic effect occurring around 1 hour and maximum effect at 4-7 hours.
Product is approaching loss of exclusivity with moderate competitive pressure (30), signaling a contracting team focused on brand defense and market maintenance rather than growth initiatives.
CLINICAL PHARMACOLOGY DDAVP Tablets contain as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. Central Diabetes Insipidus Dose response studies in patients with diabetes insipidus have demonstrated that oral doses of 0.025 mg to 0.4 mg…
Worked on DDAVP at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia
Desmopressin Acetate 0.2 mg Tablets, Fasting
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DDAVP represents a mature product career opportunity with limited growth potential but stable operational demands. Roles focus on brand defense, market maintenance, and preparation for loss of exclusivity rather than launch or expansion activities.